Precision neuropsychiatry
Our innovative programs are poised to transform the treatment landscape by solving the shortcomings of existing insomnia medicines and the challenges of psychedelic drugs. Engineered with therapeutically precise psychoactive effects and focused molecular targets, our novel formulations are designed to deliver regenerative and cost-effective treatments at scale.
We aim to provide both immediate symptom alleviation and durable, long-term, disease modifying benefits.
Innovation powered by multi-disciplinary expertise
At Reconnect Labs, we are leveraging our team’s extensive ‘bench to bedside’ experience spanning neuroscience, psychiatry, psychopharmacology, psychedelic science and clinical research to build a platform of drug candidates with the potential to treat multiple sleep, anxiety and substance use disorders.